Texas Children's ResearchersSecure Over $4M in Grants

Proud to share recent prestigious research grants secured by Faculty at Texas Children's Cancer & Hematology Center totaling over $4M. These awards highlight our faculty’s dedication to pushing the boundaries for a brighter future for our young patients.

These funds will enable us to: 

• Advance anticancer immunotherapy and targeted therapies 

• Enhance understanding of genetic & molecular mechanisms of cancers and blood disorders

• Improve treatment outcomes and quality of life for our young patients

See below for the list of recently awarded research funding (pictured above, left to right by row, starting at top left): 

• Lisa Bouchier-Hayes, PhD: The Hope Foundation (Seed Fund); Validation of a Caspase-2 Inhibitor for AML Treatment

• Andras A. Heczey, MD: American Cancer Society; Transcriptomic and Epigenetic Reprogramming of CAR T Cells Using the Motor Platform: An Unbiased Forward Genomics Approach (ACS Discovery Boost Grant) 

• Meenakshi G. Hegde, MD: Cancer Prevention and Research Institute of Texas (CPRIT); Advancing Immunotherapy for High-Risk Cancers in Children and Adolescents 

• Bilal A. Omer, MD: CPRIT; Signal-Augmented Cancer Cell Therapies: Integrating Extensive Correlatory Studies and Mentorship 

• Robin Parihar, MD, PhD: The Osteosarcoma Institute; Modified NK Cells to Decrease Toxicity and Enhance Efficacy of GD2.CAR-T for Treatment of Osteosarcoma 

• Xavier Rios Villanueva, MD, PhD: Alex's Lemonade Stand Foundation; A Award 

• Sarah E. Sartain, MD: American Cancer Society, ACS Discovery Boost Grant; The Role of KLK1 in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy 

Thank you to the funding agencies, and our collaborators, faculty, fellows, staff, volunteers and patients for supporting us and contributing to these successes.